Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Figure 1.

Summary of the literature search and sifting process (PRISMA flow diagram).

CENTRAL = Cochrane Central Register of Controlled Trials; CDSR = Cochrane Database of Systematic Reviews; DARE = Database of Abstracts of Reviews; NHS = National Health Services; HTA = Health Technology Assessment; WHO Global Medical Index = World Health Organization Global Medical Index; OpenSIGLE = System for information on Grey Literature in Europe; CDC = Centers for Diseases Control and Prevention; IFPMA = International Federation of Pharmaceutical Manufacturers Associations.

More »

Figure 1 Expand

Table 1.

Characteristics of eligible studies (n = 17).

More »

Table 1 Expand

Figure 2.

Risk of bias assessment using the Cochrane Collaboration tool.

Upper panel: RCTs and prospective cohort studies (n = 14); Lower panel: RCTs only (n = 9).

More »

Figure 2 Expand

Table 2.

Risk of bias assessment for observational studies (n = 3) excluding prospective cohort studies) using Newcastle Ottawa Quality Assessment Scale.

More »

Table 2 Expand

Figure 3.

Meta-analysis of pre- and post-exposure prophylaxis with oseltamivir against seasonal and influenza A(H1N1)pdm09 (Individual protection).

Horizontal axis represent odds ratio; Columns represent study authors and year of publication, effect size including pooled estimate of effect, and 95% CI, and the weighting of each study in the meta-analysis.

More »

Figure 3 Expand

Figure 4.

Meta-analysis of prophylaxis for households with oseltamivir against seasonal influenza.

Horizontal axis represent odds ratio; Columns represent study authors and year of publication, effect size including pooled estimate of effect, and 95% CI, and the weighting of each study in the meta-analysis.

More »

Figure 4 Expand

Figure 5.

Meta-analysis of pre- and post-exposure prophylaxis with zanamivir against seasonal influenza (individual protection).

Horizontal axis represent odds ratio; Columns represent study authors and year of publication, effect size including pooled estimate of effect, and 95% CI, and the weighting of each study in the meta-analysis.

More »

Figure 5 Expand

Figure 6.

Meta-analysis of prophylaxis for households with zanamivir against seasonal influenza.

Horizontal axis represent odds ratio; Columns represent study authors and year of publication, effect size including pooled estimate of effect, and 95% CI, and the weighting of each study in the meta-analysis.

More »

Figure 6 Expand